XML 32 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK COMPENSATION PLANS (Details Textual) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 9 Months Ended 1 Months Ended
Jan. 15, 2014
Aug. 16, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Nov. 30, 2010
Xenogenics Corporation [Member]
Aug. 31, 2013
Xenogenics Corporation [Member]
Aug. 31, 2014
Xenogenics Corporation [Member]
Aug. 31, 2013
Xenogenics Corporation [Member]
Feb. 03, 2011
Xenogenics Corporation [Member]
Oct. 31, 2010
Xenogenics Corporation [Member]
Jan. 15, 2014
Director [Member]
Aug. 16, 2013
Director [Member]
Aug. 31, 2014
Director [Member]
Aug. 31, 2013
Director [Member]
Jan. 15, 2014
Employee [Member]
Dec. 02, 2012
Equity Incentive Plan 2004 [Member]
Dec. 02, 2011
Equity Incentive Plan 2004 [Member]
Jul. 11, 2011
Equity Incentive Plan 2004 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                     8,000,000 5,000,000           1,500,000 1,500,000 70,974,213
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   5,000,000     25,074,710   2,500,000   0       4,600,000 5,000,000     2,074,710      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price   $ 0.0011     $ 0.0008   $ 0.246   $ 0       $ 0.0008 $ 0.0011     $ 0.0008      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value             $ 0.2305               $ 0.0007 $ 0.0011        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate             1.23%               1.68% 1.60%        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate             165.00%               140.00% 175.00%        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Term             5 years           5 years   5 years 5 years        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate             0.00%               0.00% 0.00%        
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options     $ 12,000   $ 12,000   $ 461,000                          
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 1 year       1 year 2 months 12 days                              
Closing Price Share     $ 0.0007   $ 0.0007                              
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent                 100.00%                      
Share-based Compensation Arrangement by Share-based Payment Award, Original Terms of Plan                 A 10% stockholder shall not be granted an ISO unless the exercise price of such option is at least 110% of the fair market value of Xenogenics common stock on the date of the grants and the option is not exercisable after the expiration of five years from the date of the grant.                      
Share-based Compensation Arrangement by Share-based Payment Award, Option, Maximum Term                 10 years                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period   5 years                                    
Allocated Share-based Compensation Expense     10,806 1,893 32,741 10,705   51,052   165,161                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Unvested, Fair Value             576,250                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares             500,000                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number             2,000,000                          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date             Nov. 30, 2015                          
Net Reversal of Stock Based Compensation Expense                 (417,838)                      
Share-based Compensation, Total     (450,194) 52,945 (385,097) 175,866     43,162                      
Share-based compensation of unvested options                 $ (461,000)